The American College of Allergy, Asthma and Immunology (ACAAI) has issued a statement regarding the use of corticosteroids for patients with allergies and asthma.
The FDA has opened a docket to gather information from the public on the use of vaping products that may be linked to recent lung injuries associated with e-cigarettes.
Practitioners can play a vital role in providing education and training on correct inhalation techniques to enhance therapeutic benefit and optimal medication delivery. Overall, the goal for the provider is to be confident when educating patients on proper use of inhalation technique, emphasize the importance of medication adherence, and maintain follow-up appointments.
More respirators, including certain N95 masks, will be made available to healthcare personnel, according to the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).
Atomoxetine plus oxybutynin demonstrated efficacy in improving upper airway collapsibility, increasing breathing stability, and reducing the threshold for arousal in obstructive sleep apnea.
In patients with COPD and hypercapnia, the use of home noninvasive positive pressure ventilation compared with no device was significantly associated with improved clinical outcomes but no significant differences in quality of life.
Organizations including the CDC and FDA have been investigating the nationwide outbreak of e-cigarette or vaping product use–associated lung injury since August 2019.
